Live healthier, stronger and sharper for longer
Daily longevity reporting — trending research, working protocols, and the supplements and peptides moving the needle on healthspan.
PeptidesSS-31 (Elamipretide) & Longevity Biomarkers: Insights for 2026
This comprehensive analysis delves into SS-31 (Elamipretide)'s potential to influence critical longevity biomarkers, offering a nuanced perspective on its evidence base as of 2026.
PeptidesARA-290 (Cibinetide): Latest Evidence &
Discover the most recent clinical evidence on ARA-290 (Cibinetide), focusing on its applications in neuropathy and anti-inflammatory pathways, with updated insights for 2026.
PeptidesARA-290 for Healthy Ageing After 50 in 2026: An
Could ARA-290 be a valuable tool for healthy ageing? This expert analysis focuses on its benefits and considerations for individuals over 50, exploring its anti-inflammatory and reparative properties.
PeptidesARA-290 & Longevity Biomarkers: 2026
Exploring ARA-290's influence on crucial longevity biomarkers, this article dissects the evidence behind its potential to modulate inflammation and cellular ageing pathways.
PeptidesPinealon and Longevity Biomarkers: What the
Pinealon, a tripeptide, is hypothesised to influence longevity pathways. We examine its potential effects on epigenetic clocks, inflammatory markers, and other key biomarkers.
PeptidesBPC-157 & Longevity Biomarkers: Unpacking
A deep dive into BPC-157's effects on crucial longevity biomarkers, evaluating the current scientific landscape and what it means for your healthspan aspirations.
PeptidesBPC-157 & Longevity Biomarkers: A 2026
BPC-157 is often lauded for its regenerative properties. We scrutinise its influence on critical longevity biomarkers, separating robust data from hopeful speculation. Find out what the science truly says.